Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
1.180
+0.130 (12.38%)
At close: Oct 8, 2025, 4:00 PM EDT
1.240
+0.060 (5.08%)
After-hours: Oct 8, 2025, 8:00 PM EDT
Myomo Market Cap
Myomo has a market cap or net worth of $44.61 million as of October 8, 2025. Its market cap has decreased by -62.07% in one year.
Market Cap
44.61M
Enterprise Value
41.55M
1-Year Change
-62.07%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since June 30, 2017, Myomo's market cap has decreased from $66.00M to $44.61M, a decrease of -32.42%. That is a compound annual growth rate of -4.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 39.70M | -79.62% |
| Dec 31, 2024 | 194.80M | 46.69% |
| Dec 29, 2023 | 132.80M | 3,588.89% |
| Dec 30, 2022 | 3.60M | -92.34% |
| Dec 31, 2021 | 47.00M | 52.60% |
| Dec 31, 2020 | 30.80M | 492.31% |
| Dec 31, 2019 | 5.20M | -70.95% |
| Dec 31, 2018 | 17.90M | -21.83% |
| Dec 29, 2017 | 22.90M | -65.30% |
| Jun 30, 2017 | 66.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |